VitaNova Life Sciences (VNOV) Depreciation and Depletion (2017 - 2018)
VitaNova Life Sciences (VNOV) posted Depreciation and Depletion of -$2367.0 for Q4 2018, down 200.0% on a QoQ basis from $2367.0 in Q3 2018, and down 246.29% year-over-year from $1618.0 in Q4 2017.
VitaNova Life Sciences (VNOV) Depreciation and Depletion (2017 - 2018) Analysis & Trends
VitaNova Life Sciences' Depreciation and Depletion history runs 2 years deep, the most recent figure standing at -$2367.0 for Q4 2018.
- Quarterly Depreciation and Depletion fell 246.29% year-over-year to -$2367.0 in Q4 2018, while the trailing twelve-month figure through Jul 2019 was -$2367.0 (changed N/A YoY) and the FY2018 annual result came in at $2848.0, up 7020.0% from the prior year.
- Depreciation and Depletion was -$2367.0 for Q4 2018 at VitaNova Life Sciences, down from $2367.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $2367.0 in Q3 2018 and bottomed at -$2367.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | 67.00 Mn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 142.30 Mn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | - |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | - |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | - |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | - |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | - |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | - |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | 112,519.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2018 | -2,367.00 |
| Oct 31, 2018 | -2,367.00 |
| Jul 31, 2018 | 2,367.00 |
| Jul 31, 2018 | 2,367.00 |
| Oct 31, 2017 | 1,618.00 |
| Oct 31, 2017 | 1,618.00 |
| Jul 31, 2017 | 120.00 |
| Jul 31, 2017 | 120.00 |